We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

A tumor-informed ctDNA MRD assay gains expanded coverage to monitor immunotherapy response in late-stage solid tumors. More...
28 Aug 2026
Image Credit: Adobe Stock

Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency

A single exome-based test detects small and large genetic variants in POI, delivering diagnoses to guide care. More...
28 Aug 2026
Image: The findings have potential implications for predicting flare-prone regions and identifying therapeutic targets for inflammatory bowel diseases. (Image Credit: iStock)

Gut “Memory” May Explain Why IBD Flares Return

Researchers identify collagen 18 as a tissue memory driver that could flag flare-prone inflammatory bowel disease regions. More...
28 Aug 2026
Image: QIAsymphony Connect delivers highly concentrated DNA and RNA for sensitive downstream assays, supporting reliable detection in liquid biopsy, oncology, and infectious disease diagnostics (Photo courtesy of Qiagen)

New Automation Platform Standardizes DNA and RNA Extraction Across Clinical Workflows

QIAGEN introduces QIAsymphony Connect IVD platform for automated clinical nucleic acid extraction. More...
28 Aug 2026
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

A tumor-informed ctDNA MRD assay gains expanded coverage to monitor immunotherapy response in late-stage solid tumors. More...
28 Aug 2026
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

A culture-coupled workflow cuts bloodstream infection diagnosis to 7 hours, enabling early pathogen ID and antibiotic guidance. More...
27 Aug 2026
Image: Study Design (Jerke, U., Kirchner, M., Bartolomaeus, T.U. et al. Nature Communcation (2026). https://doi.org/10.1038/s41467-026-75755-6)

Multiprotein Plasma Panel Identifies Remission in Vasculitis

An AI-guided proteomic panel of seven plasma proteins identifies vasculitis remission and distinguishes it from active disease. More...
27 Aug 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Immunofluorescence Analyzer
IFA System
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Copyright © 2000-2026 Globetech Media. All rights reserved.